Scholars Central

OtherPublished 13 Jul 2016

When should the sequential parallel comparison design be used in clinical trials?

Authors: Lee Baer, Anastasia Ivanova

Clinical Investigation

Volume 3 · Issue 9 · Pages 823

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Randomized clinical trials in many conditions such as mental illness, pain, addiction, allergy and asthma are subject to moderate-to-high rates of placebo response. This reduces the effect size for the comparison of the active treatment to the placebo group, hence reducing the efficiency of studies. Since attempts to resolve this problem using a placebo lead-in design have not been successful, in 2003 the sequential parallel comparison design (SPCD) was developed. In the SPCD, the study is conducted in two treatment stages, with the efficacy analysis including (a) all subjects in stage 1 and (b) stage 2 data from stage 1 placebo nonresponders. The relevant data from the two stages are pooled to compute an overall p-value. This article reviews the situations in which the SPCD is preferable to the standard parallel design as well as the circumstances in which SPCD is not a good choice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Lee Baer”
  • BylineArticles whose byline prints “Anastasia Ivanova”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels